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        Secondary exposure to antigen (Ag) in neonates 
usually leads to a lack of Th1 cells and a bias to-
ward Th2 immunity (  1  –  4  ). This unbalanced 
response may explain the susceptibility of neo-
nates to microbial infections and allergic reac-
tions (  5  ). Strategies aimed at balancing neonatal 
Th1 and Th2 responses may thus facilitate the 
development of eff  ective vaccines against infec-
tions (  6  ) and treatments for allergies (  7  ). Re-
cently, we and others have discovered that both 
Th1 and Th2 cells develop during the primary 
response to Ag in neonates (  8, 9  ). However, a 
second encounter with Ag gives rise to a strong 
Th2 response and a weak Th1 response. 
  Using OVA-specifi  c TCR transgenic (Tg) 
DO11.10 T cells (  10  ), we developed a neo-
nate-to-neonate transfer system that allows us 
to track the fate of primary Th1 cells upon ex-
posure to Ag (  11  ). In this system, neonatal 
splenic T cells from 1-d-old DO11.10/scid 
mice are transferred into newborn (1-d-old) 
BALB/c mice, which are then challenged with 
Ag i.p. 2 wk later, primary T cell responses are 
evaluated in the spleen. Secondary responses 
are examined in this model by rechallenging 
the mice with Ag in CFA at 7 wk of age and 
analyzing T cell responses 10 d later. Using this 
model, we have shown that the lack of second-
ary Th1 responses stems from the apoptosis of 
Th1 cells driven by IL-4 produced by their 
Th2 counterparts (  9  ). In this system, IL-4 does 
not signal through the conventional type I IL-4 
receptor (IL-4R    /      c  ) on Th1 cells (  12  ). Rather, 
primary exposure to Ag induces the up-regula-
tion of the IL-13R    1 chain, which associates 
with IL-4R    , giving rise to an IL-4R    /IL-
13R    1 heteroreceptor, or type II receptor, 
through which both IL-4 and IL-13 can signal 
(  13, 14  ). During in vitro recall or in vivo re-
challenge with Ag, IL-4 from the Th2 cells uti-
lizes the IL-4R    /IL-13R    1 heteroreceptor to 
drive apoptosis of Th1 cells, thus biasing the sec-
ondary immune response toward Th2 cells (  9  ). 
  In this study, we investigated the mecha-
nism underlying the up-regulation of IL-13R    1 
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  Primary neonatal T cell responses comprise both T helper (Th) cell subsets, but Th1 cells 
express high levels of interleukin 13 receptor     1 (IL-13R    1), which heterodimerizes with 
IL-4R    . During secondary antigen challenge, Th2-produced IL-4 triggers the apoptosis of 
Th1 cells via IL-4R    /IL-13R    1, thus explaining the Th2 bias in neonates. We show that 
neonates acquire the ability to overcome the Th2 bias and generate Th1 responses starting 
6 d after birth. This transition was caused by the developmental maturation of CD8      +  CD4        
dendritic cells (DCs), which were minimal in number during the fi  rst few days of birth and 
produced low levels of IL-12. This lack of IL-12 sustained the expression of IL-13R    1 on 
Th1 cells. By day 6 after birth, however, a signifi  cant number of CD8      +  CD4        DCs accumu-
lated in the spleen and produced IL-12, which triggered the down-regulation of IL-13R    1 
expression on Th1 cells, thus protecting them against IL-4  –  driven apoptosis. 
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CD8      +  CD4        DCs was reversed if IL-12 was neutralized at 
the time of Ag exposure. 
    RESULTS   
  Day 6 after birth represents a turning point 
for the expression of IL-13R    1 and the development 
of neonatal Th1 immunity 
  Previously, we developed a neonate-to-neonate TCR Tg T 
cell transfer system that was adapted to overcome the limita-
tions associated with the small size of the newborn mouse and 
made tracking T cell fate possible (  8  ). In this system, neonatal 
(1-d-old) DO11.10 TCR Tg CD4 T cells that are specifi  c for 
OVA 323  –  339 peptide (designated OVA) (  10  ) are transferred 
into BALB/c newborns (1 d old), the recipients are exposed 
to Ag, and the T cells are traced with the TCR-OVA  –  specifi  c 
anticlonotypic antibody KJ1-26 (  15  ) and analyzed for response 
to Ag. Also, as Ag we used Ig-OVA, an Ig chimera expressing 
OVA peptide within the heavy chain variable region (  9, 11  ), 
for the purpose of avoiding the use of adjuvant (  4  ) and for op-
timization of peptide presentation by uptake through Fc      re-
ceptors (Fc   Rs) ( 16  ). As indicated in  Fig. 1 , neonatal DO11.10 
T cells transferred to 1-d-old BALB/c mice and exposed to 
Ig-OVA do not produce IFN-     upon rechallenge with OVA 
peptide in CFA at adult stage (  Fig. 1 A  ).   When the transfer 
used 8-wk-old adult instead of neonatal T cells, secondary 
IFN-     responses developed. The lack of a secondary IFN-     
in neonatal Th1 cells. Our data indicate that the delayed de-
velopmental maturation of a subset of DCs leads to a shortage 
in IL-12 production, allowing for up-regulation of IL-13R    1 
expression and its association with the IL-4R     chain. Indeed, 
we show that the CD8      +  CD4        DCs accumulate to a signifi  -
cant level by day 6 after birth, a time point at which ex-
pression of IL-13R    1 decreases, leading to diminished Th1 
cell apoptosis and the restoration of IFN-     production by 
Th1 cells upon secondary Ag challenge. Neutralization of 
endogenous IL-12 on day 6 restored IL-13R    1 expression 
and apoptosis of neonatal Th1 cells, thus inhibiting secondary 
IFN-     responses, and supplying exogenous IL-12 during ex-
posure to Ag at birth decreased IL-13R    1 expression and in-
hibited apoptosis of primary Th1 cells, allowing the generation 
of secondary Th1 responses. Consistent with this, the transfer 
of wild-type adult DCs into newborn mice that had previ-
ously received neonatal DO11.10 T cells inhibited the ex-
pression of IL-13R    1, leading to the survival of primary Th1 
cells and the production of IFN-     during secondary Ag chal-
lenge. In contrast, the transfer of IL-12  –  defi  cient DCs led 
to sustained IL-13R    1 expression, Th1 cell apoptosis, and, 
thus, a lack of IFN-     production during the secondary re-
sponse. Finally, transfer of IL-12  +/+  , but not IL-12  –  defi  cient, 
adult CD8      +  CD4        DCs also inhibited IL-13R    1 expression 
and Th1 cell apoptosis, and restored secondary IFN-     pro-
duction by Th1 cells. The eff  ect of transferring IL-12  +/+   
    Figure 1.         Neonates acquire the ability to develop secondary Th1 responses when the primary encounter with Ag occurs on or beyond day 6 
after birth.   Newborn BALB/c mice were given 3   ×   10  4   neonatal or adult DO11.10 CD4 T cells and injected with 100   μ  g Ig-OVA in saline, and 2 wk later, the 
splenic cells (10  6   cells per well) were stimulated with 10   μ  M OVA peptide in vitro  .   (A) Production of IFN-     was measured by ELISA. (B) Apoptosis of IFN-    –
 producing  KJ1-26 +   Th1 cells was evaluated by Annexin V staining. In B, 10   μ  g/ml BFA was added after 6 h of stimulation with OVA peptide, and the culture 
was continued for another 6 h to facilitate intracellular accumulation of IFN-    . The cells were then labeled with KJ1-26 and Annexin V, and stained for intra-
cellular IFN-    . Histogram shows gating on KJ1-26  + /  IFN-   +   cells. (C and D) Newborn BALB/c mice were given 3   ×   10  4   neonatal DO11.10 T cells within 24 h after 
birth and were injected with 60   μ  g/g Ig-OVA (to adjust for growth) on day 1, 2, 4, 6, 8, or 10 after T cell transfer. 2 mo later, the mice were challenged with 
125   μ  g OVA peptide in CFA. 10 d later, the splenic (10  6   cells/well) and lymph node (0.5   ×   10  6   cells/well) cells were stimulated with 10   μ  M OVA peptide for 24 h, 
and production of IFN-     was determined by ELISPOT. Each bar represents the mean   ±   SD of triplicate wells. The data are representative of two experiments.    JEM VOL. 205, September 29, 2008 
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response is because of the fact that neonatal Th1 cells undergo 
apoptosis upon reencounter with OVA peptide, as indicated 
by the substantial Annexin V staining relative to adult T cells 
(  Fig. 1 B  ). However, if neonatal exposure to Ig-OVA occurs 
around day 6 after birth, the cells acquire the ability to develop 
secondary IFN-     responses both in the spleen and lymph 
node upon rechallenge with OVA/CFA at the age of 7 wk 
(  Fig. 1, C and D  ). Overall, neonates acquire the ability to de-
velop Th1 secondary responses when the initial exposure to 
Ag occurs on or beyond day 6 after birth. 
  We have previously shown that exposure to Ig-OVA at 
the neonatal stage induces up-regulation of IL-13R    1 on Th1 
cells and that such a chain associates with IL-4R     to form an 
IL-4R    /IL-13R    1 heteroreceptor (  9  ) through which both 
IL-4 and IL-13 can signal (  13, 14  ). Also, neonatal exposure to 
Ig-OVA induces both Th1 and Th2 cells in the primary re-
sponse, and upon rechallenge with OVA peptide the Th2 cells 
produce IL-4 that uses the IL-4R    /IL-13R    1 heteroreceptor 
on Th1 cells to signal for their death (  9  ). Because restoration 
of secondary IFN-     responses could occur when the primary 
exposure to Ig-OVA takes place around day 6 after birth, we 
sought to test whether at that point in time exposure to Ig-
OVA no longer sustains up-regulation of IL-13R    1 ex-
pression. Accordingly, 1-d-old BALB/c mice that had received 
neonatal DO11.10 T cells were given Ig-OVA on day 1, 2, 4, 
6, or 10 after T cell transfer, and 2 wk later their splenic Th1 
cells were isolated on the basis of IFN-     secretion and tested 
for IL-13R    1 mRNA expression. As shown in   Fig. 2 A  , IL-
13R    1 mRNA was up-regulated when exposure to Ig-OVA 
took place on day 1, 2, or 4 after birth.   However, a signifi  cant 
decrease occurred when the Ig-OVA was given on day 6 or 
10 after birth. Densitometry analysis indicated that IL-13R    1 
mRNA went down from 260% of GADPH mRNA on day 2 
to 10% on days 6 and 10, indicating an inability of the Th1 
cells to up-regulate IL-13R    1 mRNA (  Fig. 2 B  ). The de-
crease in IL-13R    1 mRNA on day 6 after birth translates into 
reduction of cell-surface IL-13R    1 protein. Indeed, IL-
13R    1 protein expression went down by 50% (from 91 to 
41%) when exposure to Ag was performed on day 6 instead of 
day 1 after birth (  Fig. 2 C  ). Furthermore, Western blot analy-
sis of Th1 T cell lysates indicated similar results, as Il-13R    1 
decreased by half upon Ag exposure on day 6 instead of day 1 
after birth (  Fig. 2 D  ). The control 1C5 CTLL-2 cells trans-
fected with the   IL-13R    1   gene (  17  ) expressed IL-13R    1 
protein, whereas the untransfected wild-type CTLL cells did 
not, indicating that the rabbit anti  –  IL-13R    1 antiserum is 
specifi  c for IL-13R    1 protein. Overall, IL-13R    1 mRNA and 
protein expression decreased signifi  cantly when exposure to 
Ag was made on day 6 after birth. 
  When IL-13R    1 mRNA expression from these Th1 cells 
during neonatal exposure to Ig-OVA was superimposed upon 
IFN-     production in the secondary response, an inverse cor-
relation between IL-13R    1 mRNA and the secondary IFN-     
response was observed (  Fig. 2 C  ). Indeed, when neonatal ex-
posure to Ig-OVA was performed on day 6, the mice began to 
develop secondary IFN-     responses when challenged with 
    Figure 2.         Recovery of neonatal IFN-     response coincides with 
down-regulation of IL-13R    1 expression.   Newborn BALB/c mice 
were given 3   ×   10  5   purifi  ed neonatal CD4  +   DO11.10 T cells and injected 
i.p. with 60   μ  g/g Ig-OVA in saline at day 1, 2, 4, 6, or 10 after birth, and 
2 wk later, the splenic cells (10  7   cells/ml) were stimulated for 10 h with 
10   μ  M OVA peptide. (A) Subsequently, Th1 cells were isolated, and RNA 
was extracted and used for analysis of   IL-13R  1   gene expression as well 
as   GAPDH   control by spot-blot technology, as described in Materials and 
methods. (B) The intensity of radioactive spots was analyzed on a Mo-
lecular Imager FX using Quantity One software and presented as a ratio 
of   IL-13R  1   to   GAPDH   after deduction of the background intensity ob-
tained with pUC19 DNA negative control. The bars represent the mean   ±   
SD of two experiments. (C and D) Newborn BALB/c mice were given 3   ×   
10  4   neonatal  CD4 +   DO11.10 T cells and injected i.p. with 60   μ  g/g Ig-OVA 
in saline at day 1 or 6 after birth, and 2 wk later, the splenic cells (10  6  
cells/ml) were stimulated for 10 h with 10   μ  M OVA peptide. In C, the 
cells were stained with KJ1-26 and rabbit anti  –  IL-13R   1  antiserum 
(1:100 dilution), and Th1 cells were identifi  ed by staining for intracellu-
lar IFN-     with  anti – IFN-    antibody. Expression of surface IL-13R   1  was 
determined by fl  ow cytometry on cells gated for KJ1-26 expression and 
intracellular IFN-     production. In D, Th1 cells were purifi  ed as in A, lysed 
using NP-40 detergent, and run on a 10% acrylamide gel. Transfer was 
made onto a nitrocellulose membrane, and IL-13R    1 protein was de-
tected using rabbit anti  –  IL-13R    1 antibodies (1:1,000 dilution). For con-
trol purposes, we used lysates from CTLL-2 cells transfected with a 
plasmid coding for cell-surface IL-13R   1  (reference   17 )  or  wild-type 
untransfected CTLL-2 cells. Band intensity was analyzed using the Mo-
lecular Imager FX, and the relative expression of IL-13R    1 represents a 
percent ratio with 1 d as 100%. Each bar represents the mean   ±   SD of 
duplicate samples. (E) IL-13R    1 mRNA expression measured by spot 
intensity from the experiments in A and B is illustrated together with 
the IFN-     production presented in   Fig. 1 C   to correlate IL-13R   1  down-
regulation together with an increase in secondary IFN-     production.   2272 ON THE ROLE OF THE CD8    + CD4       DC SUBSET IN NEONATAL IMMUNITY   | Lee et al. 
does indeed raise Th1 cells (  8, 9  ), suggesting that the lack of 
neonatal secondary Th1 immunity is not due solely to defec-
tive diff  erentiation. Given that IL-12 was shown to restore 
neonatal secondary splenic Th1 responses (  4, 11  ), we thought 
that it may accomplish this eff  ect by interfering with the 
up-regulation of IL-13R    1 expression. To test this premise, 
newborn BALB/c mice were given neonatal DO11.10 T cells 
and were administered Ig-OVA together with rIL-12. 7 wk 
later, the animals were challenged with OVA peptide in CFA 
and their splenic secondary responses were analyzed. As seen 
in   Fig. 3 A  , the mice given IL-12 developed IFN-     responses, 
whereas control animals not given IL-12 had no measurable 
IFN-     responses.   In line with these results is the observation 
that the apoptosis of Th1 cells from IL-12  –  recipient mice 
OVA peptide 2 mo later. Such IFN-     responses were even 
higher when the neonatal exposure to Ig-OVA took place on 
day 10 after birth. Overall, day 6 represents a time point at 
which exposure to Ag no longer up-regulates IL-13R    1, 
leading to the survival of IFN-      –  producing cells and the 
development of neonatal Th1 immunity. 
  Exogenous IL-12 given during exposure to Ag on the day 
of birth reduces up-regulation of IL-13R    1 on primary 
neonatal Th1 cells and restores IFN-     secondary responses 
  Previously, it has been shown that neonates demonstrate a 
poor ability to produce IL-12 (  18  ), which justifi  es the lack of 
neonatal Th1 immunity because IL-12 is a key diff  erentia-
tion factor for Th1 cells. However, the primary response 
    Figure 3.         Exogenous IL-12 inhibits developmental IL-13R    1 up-regulation and restores secondary Th1 IFN-     response in vivo.   Newborn 
BALB/c mice were given 3   ×   10  4   neonatal DO11.10 T cells within 24 h after birth. 1 d later, the recipient mice were given 100   μ  g Ig-OVA and 50 ng rIL-12. 
The mice were given additional IL-12 on days 2 and 3 after T cell transfer. 7 wk later, the mice were challenged with 125   μ  g OVA peptide in CFA, and 10 d 
after the challenge, the splenic cells (10  6   cells/well) were stimulated for 24 h with 10   μ  M OVA peptide. (A and B) Subsequently, IFN-     was measured by 
ELISPOT (A) and apoptosis was evaluated using Annexin V staining of KJ1-26  + /IFN-   +   splenic cells (B). For Annexin V staining, 10   μ  g/ml BFA was added 
during the last 8 h of peptide stimulation. Each bar in A represents the mean   ±   SD of triplicate wells. (C and D) Mice that received neonatal DO11.10 T 
cells were given Ig-OVA and IL-12 as in A, and 2 wk later, Th1 cells were isolated and   IL-13R  1   expression was assessed by spot blot (C) and real-time PCR 
(D). The real-time PCR used 200 ng RNA and the Absolute QRT-PCR SYBR kit to determine IL-13R    1 mRNA. For the spot blot in C, each bar represents the 
mean   ±   SD of duplicate spots. For the real-time PCR, the bars represent the comparative threshold cycle (C  T  ). The value of the sample from mice not re-
ceiving IL-12 was set as 1. (E and F) Newborn BALB/c mice given 3   ×   10  4   neonatal  CD4 +   DO11.10 T cells were exposed to Ig-OVA in the presence of IL-12 
as in A and B, and 2 wk later, the splenic cells (10  6   cells/ml) were stimulated for 10 h with 10   μ  M OVA peptide. The cells were then stained with KJ1-26 
and rabbit anti  –  IL-13R    1 antiserum (1:100 dilution), and Th1 cells were identifi  ed by staining for intracellular IFN-     with  anti – IFN-    antibody.  Expression 
of surface IL-13R    1 was determined by fl  ow cytometry on cells gated for KJ1-26 expression and intracellular IFN-     production.   JEM VOL. 205, September 29, 2008 
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  Day 6 transition to Th1 responses is caused 
by an acquired ability of the neonate to produce IL-12 
that down-regulates IL-13R    1 and sustains the survival 
of IFN-      –  producing T cells 
  Because exogenous IL-12 was able to reduce IL-13R    1 ex-
pression and rescue neonatal primary Th1 cells similar to Ag 
exposure on day 6, we postulated that the newborn acquires the 
ability to produce signifi  cant IL-12 on day 6, which results in 
IL-13R    1 down-regulation and rescue of Th1 immunity. To 
test this premise, mice were given Ig-OVA and anti  –  IL-12 an-
tibody on day 6 after birth, challenged with OVA peptide in 
CFA 2 mo later, and tested for IFN-     production as well as Th1 
apoptosis.   Fig. 4   A shows that neutralization of IL-12 during 
exposure to Ig-OVA on day 6 reduces IFN-     production 
to minimal levels comparable to those observed with day 1 
was signifi  cantly reduced relative to control animals not given 
IL-12 (  Fig. 3 B  ). When the animals were evaluated for 
IL-13R    1 expression 2 wk after exposure to Ig-OVA/IL-12 
but before any rechallenge with OVA/CFA, the primary Th1 
cells had signifi  cantly reduced IL-13R    1 mRNA relative to 
mice given Ig-OVA but no IL-12, as measured by spot blot 
(  Fig. 3 C  ) and real-time PCR (  Fig. 3 D  ). Again, when the 
cells were analyzed for IL-13R    1 protein, the supply of ex-
ogenous IL-12 together with Ig-OVA reduced IL-13R    1 
protein expression from 84 to 41% when compared with 
cells from mice that did not receive IL-12. (  Fig. 3, E and F  ). 
Overall, exogenous IL-12 was capable of down-regulating 
IL-13R    1 on primary Th1 cells, which inhibited their apop-
tosis during rechallenge with OVA peptide and restored the 
secondary IFN-     responses. 
    Figure 4.         Neutralization of IL-12 on day 6 after birth nullifi  es IFN-     response through up-regulation of IL-13R    1 and apoptosis of Th1 
cells.   Newborn BALB/c mice were given 3 x 10  4   CD4 neonatal DO11.10 T cells within 24 h after birth. On day 6, the hosts were given 60   μ  g/g Ig-OVA and 
50   μ  g anti  –  IL-12 antibody per mouse or rat IgG. Another injection of anti  –  IL-12 antibody or rat IgG was given on days 7 and 8. A group of mice that 
received Ig-OVA on day 1 and no anti  –  IL-12 antibody at any time was included as a control. 7 wk later, all groups were challenged with 125   μ  g OVA pep-
tide in CFA. 10 d later, the splenic cells (10  6   cells/well) were stimulated with 10   μ  M OVA peptide and assayed for (A) IFN-     production by ELISPOT and (B) 
apoptosis by Annexin V staining, as in   Fig. 3  . Each bar represents the mean   ±   SD of triplicate wells. (C and D) Mice that received neonatal DO11.10 T cells 
were given Ig-OVA and anti  –  IL-12 antibody as in A, and 2 wk later, primary Th1 cells were isolated and IL-13R    1 expression was assessed by spot blot (C) 
and real-time PCR (D), as described in   Fig. 3  . For the spot blot in C, each bar represents the mean   ±   SD of duplicate spots. For the real-time PCR, the bars 
represent the comparative threshold cycle (C  T  ). The value of the sample from mice that received rat IgG was set as 1. (E and F) Newborn BALB/c from A 
and B that received anti  –  IL-12 antibody or rat IgG control during exposure to Ig-OVA on day 6 were killed 2 wk later, and the splenic cells were stained 
with KJ1-26 and rabbit anti  –  IL-13R    1 antiserum (1:100 dilution). The Th1 cells were identifi  ed by staining for intracellular IFN-     with  anti – IFN-    anti-
body, and expression of surface IL-13R    1 was determined by fl  ow cytometry on cells gated for KJ1-26 expression and intracellular IFN-     production.   2274 ON THE ROLE OF THE CD8    + CD4       DC SUBSET IN NEONATAL IMMUNITY   | Lee et al. 
DCs (  11  ). It is thus possible that the lack of IL-12 in the neo-
nates is caused by delayed developmental accumulation of 
DCs. To test this assumption, we enriched the neonates with 
splenic DCs from adult mice and tested them for rescue of 
primary neonatal Th1 cells from apoptosis and development 
of secondary Th1 IFN-     responses. As can be seen in   Fig. 5  , 
binding of Annexin V to neonatal Th1 DO11.10 T cells de-
creased from 87% in the mice that did not receive DCs (Nil) 
to 12% in those that received DCs from IL-12  –  suffi   cient (IL-
12  +/+  ) mice (IL-12  +/+   DCs;   Fig. 5, A and B  ).   Transfer of 
DCs from IL-12  –  defi  cient (IL-12      /     ) (  20  ) instead of IL-
12  +/+   mice did not reduce Th1 cell death, as binding of An-
nexin V was observed on 86% of the Th1 cells in comparison 
to 87% in the mice with no DC transfer (compare   Fig. 5 C   
with   Fig. 5 A  ). The primary Th1 cells from the IL-12  +/+   
DC  –  enriched mice had reduced expression of IL-13R    1 
mRNA relative to T cells of mice that were transferred with 
IL-12      /      DCs or animals that did not receive DC transfer 
(  Fig. 5 D  ). Furthermore, when the mice were challenged 
with OVA/CFA at 7 wk of age, those recipients of IL-12  +/+   
DCs developed secondary IFN-     responses, whereas animals 
that were not given DCs or received IL-12      /      DCs had min-
imal IFN-     responses (  Fig. 5 E  ). The conclusion to be drawn 
from these experiments is that enrichment with IL-12  +/+   DCs 
is similar to treatment with exogenous IL-12, which reduces 
IL-13R    1 expression by Th1 cells, leading to the inhibition 
of apoptosis and restoration of secondary IFN-     responses. 
exposure to Ag, whereas rat IgG  –  injected mice sustain signifi  -
cant IFN-     responses.   Also, apoptosis of Th1 cells was more 
substantial in the mice given anti  –  IL-12 antibody versus recipi-
ents of rat IgG (  Fig. 4 B  ). These results indicate that the restora-
tion of secondary Th1 responses upon delay of Ag exposure to 
day 6 after birth operates through the production of endog-
enous IL-12. Interestingly, IL-13R    1 mRNA expression ana-
lyzed 2 wk after day 6 Ag exposure was signifi  cantly up-regulated 
in the mice given anti  –  IL-12 antibody versus those recipients of 
rat IgG instead (  Fig. 4, C and D  ). Similar results were observed 
when the cells were analyzed for IL-13R    1 protein expression 
(  Fig. 4, E and F  ). Indeed, neutralization of IL-12 with ant  –  IL-
12 antibody during day 6 exposure to Ig-OVA reduced IL-
13R    1 protein expression from 72 to 43% relative to cells from 
mice that received the control rat IgG instead of anti  –  IL-12 an-
tibody. Overall, the fi  ndings suggest that the newborn mice ac-
quire the ability to produce signifi  cant IL-12 by day 6 after birth 
that is suffi   cient for down-regulation of IL-13R    1, survival of 
Th1 cells, and restoration of secondary IFN-     responses. 
  Enrichment with adult DCs inhibits IL-13R    1 up-regulation 
on primary neonatal Th1 cells and restores secondary 
IFN-     responses 
  IL-12 is produced by APCs, most signifi  cantly by DCs, dur-
ing Ag presentation and direct T cell diff  erentiation to Th1 
(  19  ). Most of the APCs in the neonate, however, are com-
posed of macrophages and B cells, with a minimal number of 
    Figure 5.         Transfer of adult IL-12  +/+   but not IL-12      /      DCs into newborn mice down-regulates IL-13R    1 expression, inhibits apoptosis, and 
restores secondary Th1 IFN-     responses.   Newborn (1-d-old) BALB/c mice were given 3   ×   10  4   neonatal DO11.10 T cells without (Nil) or with 2   ×   10  5  
splenic DCs from adult wild-type (IL-12  +/+   DCs)  or  IL-12 – defi  cient (IL-12     /     DCs) BALB/c mice (reference   20  ) and were injected 1 d later with 100   μ  g Ig-
OVA. After 7 wk, the mice were challenged with 125   μ  g OVA peptide in CFA, and 10 d later, the splenic cells (10  6   cells/well) were stimulated with 10   μ  M 
OVA peptide for 24 h. (A  –  C) Apoptosis of KJ1-26  + /IFN-   +   Th1 cells was evaluated by staining with Annexin V, as described in   Fig. 3  . (D) Groups of mice 
were killed 2 wk after T cell/DC transfer and exposure to Ig-OVA, and primary Th1 cells were isolated using IFN-     secretion kit, as described in Materials 
and methods. RNA was then extracted and IL-13R    1 expression was determined by spot blot, as in   Fig. 2  . Because IL-13R    1 mRNA parallels with protein 
expression (see   Figs. 2, 3, and 4  ), all follow-up experiments will use mRNA analysis on separated Th1 cells. (E) IFN-     production was measured using 
ELISPOT assay. Each bar represents the mean   ±   SD of duplicate spots.     JEM VOL. 205, September 29, 2008 
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CD8  +  CD4        DC transfer is dependent on IL-12. This state-
ment emanates from the observation that IL-12      /      CD8  +  CD4        
DC transfer does not inhibit the apoptosis of Th1 cells (  Fig. 
7 F  ), but a supply of exogenous IL-12 together with the 
IL-12      /      CD8  +  CD4        DC transfer restores the reduction of 
Annexin V binding to Th1 cells (  Fig. 7 H  ). Finally, secondary 
IFN-     responses did occur with the IL-12  +/+   CD8      +  CD4        
DCs, but not with the IL-12      /      CD8      +  CD4        or even the 
  Delayed developmental accumulation of the CD8      +  CD4        
subset of DCs in the neonates leads to minimal IL-12 
production, signifi  cant up-regulation of IL-13R    1 
expression, death of primary Th1 cells, and lack 
of secondary IFN-     responses 
  Because DCs were able to reduce IL-13R    1 expression, in-
hibit apoptosis of primary Th1 cells, and restore secondary 
IFN-     responses, we sought to determine whether delayed de-
velopmental accumulation of a specifi  c subset of DCs is re-
sponsible for the up-regulation of IL-13R    1 by virtue of 
minimal IL-12 production leading to the death of primary Th1 
cells and a lack of secondary IFN-     responses. The splenic 
CD11c  +   DCs comprise both CD8      +   and CD8            DCs (  21  ). 
Also, some of the CD8            DCs can express CD4, and as such 
are further divided into CD8           CD4  +   and CD8           CD4        DCs. 
Initially, we determined the kinetics of accumulation of various 
subsets of DCs in the splenic neonate between the day of birth 
and day 10 of age. As indicated in   Fig. 6  , most splenic CD11c  +   
DCs were negative for CD8     and CD4.   However, by day 4 
the number of CD8           CD4  +   DCs rose to 11.2% among the 
total CD11c  +   DCs, whereas CD8      +  CD4        DCs made up 3.3% 
of total CD11c  +   cells. By day 6, both subsets reached a number 
that was more or less similar to days 8 and 10, which ranged 
between 13 and 16% for CD8           CD4  +   and between 3.8 and 
4.3% for CD8      +  CD4        DCs (  Fig. 6  ). These numbers are 
much lower than those observed in adult mice (40.4% for 
CD8           CD4  +   and 16% for CD8      +  CD4        DCs), indicating 
that developmental accumulation is not complete by day 10. 
In fact, CD8      +  CD4  +   DCs, which make up a very small frac-
tion of total adult CD11c  +   DCs, remain insignifi  cant at day 10 
of age. Because day 6 was a turning point for the develop-
ment of Th1 secondary immunity and the CD8           CD4  +   and 
CD8      +  CD4        DC subsets have undergone a signifi  cant increase 
in number between birth and day 6, we tested both popu  lations 
for reduction of IL-13R    1 up-regulation, inhibition of apop-
tosis of Th1 cells, and restoration of secondary IFN-    responses. 
Accordingly, newborn BALB/c mice were transferred with 1-d-
old DO11.10 T cells with the CD8           CD4  +   or CD8      +  CD4        
adult DC subset from either IL-12  +/+   or IL-12      /      mice and 
were exposed to Ig-OVA. 2 wk later, Th1 cells were isolated 
and IL-13R    1 mRNA expression on primary neonatal Th1 
cells was evaluated by spot blot.   Fig. 7   A shows that up-regula-
tion of IL-13R    1 expression occurred when the mice received 
no DC transfer or transfer with IL-12  +/+   CD8           CD4  +   DCs.   
However, up-regulation of IL-13R    1 expression was minimal 
when the animals were transferred with IL-12  +/+   CD8     +  CD4        
DCs (  Fig. 7 A  ). Transfer of IL-12      /      CD8      +  CD4        DCs did 
not reduce IL-13R    1 mRNA expression on Th1 cells (  Fig. 
7 A  ). Moreover, apoptosis of Th1 cells was reduced signifi  -
cantly with the transfer of IL-12  +/+   CD8      +  CD4        DCs relative 
to IL-12  +/+   CD8           CD4  +   or no DC transfer (  Fig. 7, C  –  E  ). In-
deed, 83 and 87% of primary Th1 cells bind Annexin V when 
the transfer used no DCs or IL-12  +/+   CD8           CD4  +   DCs, re-
spectively (  Fig. 7, C and D  ). Only 45% of primary Th1 cells 
bound Annexin V when the transfer was made with IL-12  +/+   
CD8      +  CD4        DCs (  Fig. 7 E  ). Inhibition of T cell death by 
    Figure 6.         Developmental accumulation of CD8      +  CD4            and 
CD8               CD4  +   DCs occurs at day 6 after birth.   Splenic cells (10  6   cells/
tube) from 1-, 2-, 4-, 6-, 8-, and 10-d-old BALB/c neonates were stained 
with anti-CD11c, anti-CD4, and anti-CD8     antibodies,  fi  xed with 2% 
formaldehyde, and analyzed by FACS. Expression of CD4 and CD8     was 
analyzed on cells gated on CD11c. Splenic cells from adult (8-wk-old) 
BALB/c mice were included as control. Percentages of cells are shown.     2276 ON THE ROLE OF THE CD8    + CD4       DC SUBSET IN NEONATAL IMMUNITY   | Lee et al. 
DCs, stimulate them with CpG, and test for intracellular IL-12 
on gated DC subsets.   Fig. 8 B   shows that on day 1 after birth 
most of the splenic DCs are CD8           CD4       , with almost no 
CD8      +  CD4        or CD8       CD4  +   DC subsets. By day 6, however, 
both CD8      +  CD4        and CD8       CD4  +   DC subsets reached sig-
nifi  cant frequency, as was shown in   Fig. 6  . When tested for 
intracellular IL-12, 26% of the CD8           CD4        double-nega-
tive and most frequent subset produced IL-12 on day 1 after 
birth, and 6 d later 84% of the cells displayed IL-12 expression 
(  Fig. 8 C  ). This points to a developmental infl  uence on these 
DCs to produce IL-12 cytokine. As for the CD8      +  CD4        
DCs, like the CD8           CD4  +   DCs, there was no detectable 
IL-12 on day 1 but the majority of the cells available on day 6 
produced IL-12 (84 and 97%, respectively;   Fig. 8, D and E  ). 
These results indicate that the limited availability of IL-12 on 
the day of birth is caused by delayed accumulation of the DC 
subsets in the spleen, together with a progressive ability to 
produce IL-12 cytokine. 
    DISCUSSION   
  Neonatal exposure to Ag leads to secondary responses that are 
usually biased toward Th2 upon rechallenge with Ag later (  1  –  4  ). 
IL-12  +/+   CD8           CD4  +   DC transfer (  Fig. 7 B  ). Supply of 
exogenous IL-12 with the IL-12      /      CD8      +  CD4        DCs 
restored IFN-     secondary responses. Furthermore, neutraliza-
tion of IL-12 during IL-12  +/+   CD8      +  CD4        DC transfer by 
injection of anti  –  IL-12 antibody restored apoptosis of primary 
Th1 cells (  Fig. 7 B  ). These results indicate that CD8      +  CD4        
DCs provide suffi   cient IL-12 needed for down-regulation of 
IL-13R    1, inhibition of apoptosis, and restoration of second-
ary Th1 responses. 
  To determine whether the limited availability of IL-12 
on the day of birth is caused by delayed accumulation of 
CD8      +  CD4        DCs or by an inability of these APCs to pro-
duce IL-12, we isolated neonatal CD11c  +   DCs at diff  erent 
time points after birth, stimulated the cells with the DC stim-
ulator CpG dinucleotide, and tested for IL-12 production. As 
indicated in   Fig. 8  , neonatal DCs gain the ability to produce 
IL-12 progressively over time and reach a maximum at adult 
age (  Fig. 8 A  ).   However, these results do not distinguish be-
tween an increase in the number of CD8      +  CD4        DCs or 
the gain of ability to produce IL-12 cytokine. Given that iso-
lation of the DC subsets at early neonatal age is not feasible 
because of low frequency, we opted to purify total CD11c  +   
    Figure 7.         The CD8      +  CD4            but not the CD8               CD4  +   DC subset inhibits up-regulation of IL-13R    1, prevents apoptosis, and restores neonatal 
IFN-     responses.   Newborn BALB/c mice were given neonatal DO11.10 T cells without (Nil) or with 10  5   CD8   + CD4       or  CD8       CD4 +   DCs from adult IL-
12  +/+   or IL-12     /     BALB/c mice and were injected 24 h later with 100   μ  g Ig-OVA. (A) The mice were killed within 2 wk, primary Th1 cells were isolated on 
the basis of IFN-     secretion, and IL-13R    1 expression was evaluated by spot blot. Each bar represents the mean   ±   SD of duplicate spots. (B  –  H) 7 wk after 
exposure to Ig-OVA the mice were challenged with 125   μ  g OVA peptide in CFA. 10 d later, the splenic cells (10  6   cells/well) were stimulated for 24 h with 
10   μ  M OVA peptide, and production of IFN-     was measured by ELISPOT (B) and apoptosis was evaluated by Annexin V staining of KJ1-26  + /IFN-   +   splenic 
cells (C  –  H). For neutralization of endogenous IL-12 where indicated (IL-12  +/+   CD8   + CD4      /anti  –  IL-12), the mice were given i.p. 50   μ  g anti  –  IL-12 antibody 
(clone C17.8) on days 1, 2, and 3 after neonatal transfer of DO11.10 T cells and DCs. For stimulation with OVA peptide in the presence of rIL-12 where 
indicated (IL-12     /   CD8   + CD4       + IL-12), the culture was supplemented with 2 ng/ml rIL-12. Each bar in B represents the mean   ±   SD of triplicate wells.     JEM VOL. 205, September 29, 2008 
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indicated that although CD11c  +   CD8           CD4        DCs were 
present at a signifi  cant number on the day of birth, the 
CD8      +  CD4        and CD8           CD4  +   subsets began to accumulate 
in the spleen by day 4 and reached a signifi  cant percentage by 
day 6 (  Fig. 6  ). A small population of CD8      +  CD4  +   DCs that is 
present in adult mice was not detected by day 10 after birth. 
Thus, these observations suggested that it is the CD8      +  CD4        
and/or the CD8           CD4  +   subset that might be responsible for 
the acquired ability of the neonate to develop secondary Th1 
Recent investigations indicated that both Th1 and Th2 cells 
develop in the neonatal primary response, but secondary en-
counter with Ag leads to death of the Th1 cells by apoptosis, 
hence the bias toward Th2 cells (  9  ). The death of Th1 cells 
stems from an up-regulation of the IL-13R    1 chain during 
neonatal exposure to Ag (  9  ). Indeed, it was shown that the 
IL-13R    1 chain associates with IL-4R     to form an IL-4R    /
IL-13R    1 heteroreceptor through which both IL-4 and IL-
13 cytokines can signal (  13, 14  ). During rechallenge with Ag, 
IL-4 from the Th2 cells utilizes the IL-4R    /IL-13R    1 het-
eroreceptor and induces the death of Th1 cells (  9  ). In this pa-
per, we show that day 6 after birth is a turning point at which 
exposure to Ag no longer results in secondary responses that 
are biased toward Th2 and secondary Th1 IFN-     responses 
emerge (  Fig. 1  ). These observations bode well with fi  ndings 
indicating that exposure to Ag at day 7 but not at day 3 be-
come eff  ective in inducing Th1 responses (  22  ). Interestingly, 
day 6 after birth also represents a turning point for the ex-
pression of IL-13R    1, as exposure to Ag at this age no longer 
up-regulates IL-13R    1 mRNA or protein expression on Th1 
cells (  Fig. 2  ). We then set up experiments and investigated the 
mechanism underlying the restoration of neonatal Th1 sec-
ondary responses by day 6 Ag exposure. We have previously 
shown that IL-12 can rescue splenic Th1 cells and restore IFN-     
production (  4, 11  ). Given that the neonate displays an inabil-
ity to produce signifi  cant IL-12 (  19, 23  ), we thought that ex-
posure to Ag within an environment where IL-12 is limited 
may be responsible for up-regulation of IL-13R    1 and the 
consequent death of Th1 cells. This assumption proved cor-
rect, as exogenous IL-12 given during Ag exposure on day 1 
reduced IL-13R    1 mRNA and protein expression on primary 
Th1 cells, inhibited their apoptosis, and restored secondary 
IFN-     responses (  Fig. 3  ). Moreover, it was shown that the 
administration of anti  –  IL-12 antibody during Ag exposure on 
day 6 after birth nullifi  es restoration of secondary IFN-     
responses, and this operates through the restitution of IL-
13R    1 up-regulation and apoptosis of Th1 cells (  Fig. 4  ). 
  Given that DCs are the main producers of IL-12 and that 
the neonatal environment is composed of lower numbers of 
DCs relative to other APCs (  11  ), it is possible that the inabil-
ity of the neonatal environment to provide signifi  cant IL-12 
is related to the minimal number of Ag-presenting DCs avail-
able at day 1 after birth. In fact, when newborn mice were 
enriched with adult IL-12  +/+   splenic DCs, up-regulation of 
IL-13R    1 on primary Th1 cells was minimal, apoptosis was 
signifi  cantly reduced, and secondary Th1 IFN-     responses 
were restored (  Fig. 5  ). IL-12      /      DCs could not inhibit IL-
13R    1 up-regulation or restore Th1 IFN-     responses. These 
observations, together with the day 6  –  acquired neonatal tran-
sition to secondary Th1 responses, suggest that developmen-
tal accumulation of DCs could be responsible for the bias of 
neonatal immunity toward Th2. Given that distinct subsets of 
DCs can perform diff  erent functions (  24  –  27  ), delayed devel-
opmental accumulation of a specifi  c subset of CD8      +/     CD4  +/      
DCs over time could orchestrate the Th2 bias of neonatal 
immunity. Analysis of DC ontogeny in the neonate mouse 
    Figure 8.         The limited availability of IL-12 during neonatal expo-
sure to Ag is related to delayed accumulation in the spleen of the 
presenting CD8      +  CD4            DC subset.   Newborn BALB/c mice were killed 
at the indicated day after birth, and splenic CD11c  +   DCs were isolated on 
anti-CD11c microbeads. (A) The DCs (100   ×   10  3   cells per well) were stim-
ulated with 6   μ  g/ml CpG, and 24 h later, IL-12 was measured by ELISA. 
Each bar represents the mean   ±   SD of triplicate wells. (B  –  E) 1- and 6-d-
old DCs (100   ×   10  3   cells per well) were purifi  ed from the spleens of 45 
newborns, and 10  6   CD11c +   cells were stimulated with 6   μ  g/ml CpG for 
10 h, after which BFA was added and the culture was continued for 4 h 
to facilitate intracellular cytokine accumulation. Subsequently, the cells 
were stained with anti-CD11c, anti-CD4, and anti-CD8 antibodies and 
permeabilized with 2% saponin. Intracellular IL-12 was detected by 
staining with anti  –  IL-12 p70 antibody. B shows the frequency of the 
subsets, and C  –  E illustrates fl  ow cytometry plots of intracellular IL-12 
on the indicated subset. ND, not detected.     2278 ON THE ROLE OF THE CD8    + CD4       DC SUBSET IN NEONATAL IMMUNITY   | Lee et al. 
were conducted according to the guidelines of the University of Missouri 
Columbia Animal Care and Use Committee. 
  Ag  ’  s 
  OVA peptide (SQAVHAAHAEINEAGR) encompasses aa residues 323  –  339 
of OVA and is immunogenic in BALB/c (H-2  d  ) mice. Ig-W, a BALB/c 
IgG2b Ig molecule generated by transfection of the 91A3 antiarsonate anti-
body heavy and light chains into the non  –  Ig-secreting myeloma B cell line 
SP2/0, was previously described (  4  ). Ig-OVA, expressing OVA peptide within 
the heavy chain variable region of Ig-W, was also previously described (  11  ). 
ODN1826 or CpG oligonucleotide was purchased from InvivoGen. 
  Generation of rabbit anti  –  IL-13R    1 antibodies 
  Expression and purifi   cation of IL-13R    1 protein.     The plasmid 
pQE30  –  IL-13R    1 (  31  ), a gift from A. Gessner (Institut f  ü  r Klinische 
Mikrobiologie, Immunologie und Hygiene, Erlangen, Germany), was di-
gested with SphI and XhoI to liberate a cDNA that encodes the extracellular 
domain of IL-13R    1 (aa 27  –  339) with an N-terminal His tag. This frag-
ment was ligated into pFastBac plasmid (Invitrogen) to generate pFastBac  –
  IL-13R    1, which was then used to generate baculovirus and to express 
rmIL-13R    1 in Sf9 cells, according to the manufacturer  ’  s instructions. IL-
13R    1 protein was purifi  ed using Ni-NTA agarose beads from QIAGEN, 
as previously described (  32  ). 
  Rabbit immunization with IL-13R    1 protein.     A New Zealand white 
rabbit was immunized with 50   μ  g rIL-13R    1 in CFA/PBS, as previously de-
scribed (  33  ). A subsequent immunization with 50   μ  g rIL-13R    1 in IFA/PBS 
was given monthly for 3 mo. 
  Adoptive T cell transfer 
  Splenic cells from 1-day-old DO11.10/scid mice containing the equiva-
lent of 30   ×   10  3   DO11.10 T cells were transferred into 1-day-old BALB/c 
mice by i.v. injection through the facial vein using a 30-gauge needle. To 
obtain four experimental newborn BALB/c hosts, 12 DO11.10/scid neo-
natal mice were used. For the transfer of adult T cells into newborn mice, 
DO11.10 T cells were purifi  ed from the spleens of adult DO11.10/scid 
mice with anti-CD4 antibody  –  coupled magnetic beads (Miltenyi Biotec) 
before injection into the host. In this case, two to three adult DO11.10/
scid mice are needed to generate four neonatal BALB/c hosts. When the 
analysis requires separation of Th1 from Th2 cells, the transfer used 300   ×   
10  3   purifi  ed rather unseparated neonatal DO11.10/scid T cells. In this case, 
60 newborn DO11.10/scid mice are needed to generate four BALB/c hosts. 
This 10-fold increase in T cell transfer was required for the isolation of 
suffi   cient numbers of T cells for RNA extraction and spot blot and real-
time PCR analysis. 
  Detection of apoptosis by staining with Annexin V 
  For cell-surface staining, the splenic cells from BALB/c hosts that received 
neonatal DO11.10/scid T cells and Ig-OVA were incubated for 20 min at 4  °  C 
with 5   μ  g/ml 2.4G2 mAb to block Fc    Rs on the cell surface before staining. 
The cells were then stained with the anti-TCR OVA clonotypic mAb KJ1-26 
(mouse IgG2a) and FITC  –  Annexin V (BD Biosciences). Cytokine secretion 
was blocked by the addition of 10   μ  g/ml Brefeldin A (BFA; Epicentre), and 
the cells were fi  xed with 2% formaldehyde, permeabilized with 2% saponin 
(Sigma-Aldrich) in PBS buff  er for 10 min at room temperature, and incubated 
with PE  –  anti  –  mouse IFN-    . Isotype-matched controls were included in all 
experiments. All data were collected using a fl  ow cytometer (FACScan; Bec-
ton Dickinson) and were analyzed with CellQuest software (Becton Dickin-
son) and Flowjo software (Tree Star, Inc.). 
  Separation of Th1 cells 
  The separation of neonatal Th1 from Th2 cells requires an increased frequency 
of primary T lymphocytes. To overcome this technical diffi   culty, the transfer 
was performed with purifi  ed neonatal DO11.10/scid T lymphocytes instead of 
total splenic cells, and the number of transferred cells was increased from 30 to 
300   ×   10  3   cells per newborn BALB/c host. Consequently, each T cell subset 
responses when exposure to Ag is performed on day 6 after birth. 
In fact, when the CD8      +  CD4       , but not the CD8           CD4  +  , 
subset was transferred to newborns on the day of birth during 
exposure to Ag, the primary Th1 cells displayed signifi  cantly 
reduced IL-13R    1 expression, resisted apoptosis, and devel-
oped secondary IFN-     responses when the animals were re-
challenged with OVA as adults (  Fig. 7  ). Transfer of IL-12      /      
CD8      +  CD4        DCs was not able to overturn IL-13R    1 up-
regulation or restore IFN-     secondary Th1 responses, indi-
cating that the subset presents Ag and produces the IL-12 
needed to counter IL-13R    1 up-regulation. Moreover, in-
vestigation of the frequency of the DC subsets indicated that 
a minimal number of the presenting CD8      +  CD4        DC subset 
is present in the spleen on the day of birth. At best, these cells 
could produce IL-12 at a limited rate, like the CD8           CD4        
double-negative DC subset (  Fig. 8  ), but this would be insuf-
fi  cient to counter IL-13R    1 up-regulation. By day 6, the 
frequency of the CD8      +  CD4        DC subset increased because 
of signifi  cant accumulation of this subset (  Fig. 8  ). In addition, 
most of the cells produced IL-12, leading to inhibition of IL-
13R    1 up-regulation, diminished apoptosis of primary Th1 
cells, and development of secondary Th1 responses. 
  Collectively, these observations indicate that delayed de-
velopmental maturation of a subset of DCs operates the Th2 
bias of neonatal immunity. In particular, our data suggest that 
minimal production of IL-12 in early neonatal life because of 
delayed accumulation of the CD8      +  CD4        DC subset leads to 
up-regulation of IL-13R    1 on primary Th1 cells. This chain 
associates with IL-4R     and forms an IL-4R    /IL-13R    1 
heteroreceptor (  13, 14  ). IL-4 from the Th2 cells used this re-
ceptor to drive apoptosis of Th1 cells, leading to a lack of 
secondary Th1 immunity, and hence the bias to Th2 cells (  9  ). 
These observations agree with previous papers showing a de-
layed developmental accumulation of DCs (  28, 29  ). What this 
study adds is that a specifi  c subset is responsible for Ag pre-
sentation and IL-12 production, and it ties the regulation of 
IL-13R    1 to such IL-12 and the developmental maturation 
of the CD8      +  CD4        DC subset during the neonatal period. 
Also, we demonstrate that suffi   cient accumulation of the 
CD8      +  CD4        DC subset by day 6 after birth represents a turn-
ing point to down-regulate IL-13R    1 and sustain the transition 
for Th1 responses. These previously unrecognized fi  ndings 
highlight the mechanism underlying the bias of neonatal im-
munity toward Th2 cells and provide useful information for 
the development of pediatric vaccines and reagents against 
allergies in infants and children (  30  ). 
  MATERIALS AND METHODS 
  Mice 
  BALB/c (H-2  d  ) mice were purchased from Harlan Sprague Dawley and 
were used as hosts for the adoptive transfer of T cells. DO11.10/scid Tg 
mice expressing a TCR specifi  c for OVA peptide (  10  ) were used as T cell 
donors. IL-12      /      mice in which the   IL-12p35   gene was knocked out (  20  ) 
were obtained from the Jackson Laboratory and were used as a source for 
DC transfer. New Zealand white rabbits were purchased from Myrtle  ’  s 
Rabbitry. All animals were maintained in the animal facility for the duration 
of the experiments. Experimental procedures performed on these animals JEM VOL. 205, September 29, 2008 
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  Spot blot for detection of   IL-13R    1   expression 
  Because of the small number of isolated Th1 cells, RNA purifi  cation yields 
small amounts insuffi   cient to perform Northern blot analysis. We devel-
oped a spot-blot technology to overcome these limitations and performed 
  IL-13R    1   analysis by both spot blot and real-time PCR. Accordingly, a 
1-kb   IL-13R    1   DNA fragment was digested from pCEP4IL-13R    1 plasmid 
with BamH1 and purifi  ed by electroelution from a 1% agarose gel. 1   μ  l Tris 
buff  er containing 5 ng IL-13R    1, pUC19 or   GAPDH   DNA was deposited 
within marked circular spots on a nylon transfer membrane (Magnacharge; 
Osmonics). Duplicate spots were made for each sample. The membrane 
was dried for 30 min at 60  °  C, and the DNA was denatured in 0.5 N NaOH 
and neutralized with 0.5 M Tris buff  er. The membrane was then used for 
detection of IL-13R    1 mRNA. Total RNA was extracted from 0.5  –  1   ×   
10  6   purifi  ed Th1 cells using TRI  zol   reagent (Life Technologies). 5   μ  g 
RNA was used in an RT reaction together with     -[  32  P]dCTP (GE Health-
care) to generate labeled cDNA probes by using the Ampolabeling-LRP kit 
(SuperArray Inc.). The specifi  c primers for the amplifi  cation of target genes 
were purchased from SuperArray Inc. Subsequently, the labeled cDNA 
probes were hybridized to the membrane in a 0.75-ml hybridization buff  er 
for 24 h at 60  °  C. The intensity of radioactive spots was analyzed on a 
Molecular Imager FX (Bio-Rad Laboratories) using Quantity One software. 
Results were expressed as arbitrary units estimated as follows: (mean spot 
density of sample      mean spot density of background)/(mean spot density 
of GAPDH      mean spot density of background). The background repre-
sents the mean radioactive intensity obtained from pUC19 DNA spots in-
cluded in the membrane. 
  Real-time PCR 
  RT and DNA amplifi  cation were performed according to a one-step proto-
col using 200 ng of total RNA and an Absolute MAX QRT-PCR SYBR 
Mix (ABgene), according to the manufacturer  ’  s instructions. Expression of 
IL-13R    1 chain mRNA was assessed in neonatal Th1 cells.     -actin was 
included to serve as a normalizer. The oligonucleotides used as specifi  c 
primers were as follows: sense, (IL-13R    1) 5    -GCACAGAGTATAGGTA-
AGGAGCAA-3     and (    -actin) 5    -AGAGGGAAATCGTGCGTGAC-3    ; 
and antisense, (IL-13R    1) 5    -ACAAAGACTGGAATGGTGAGTAAC-3     
and (    -actin) 5    -CAATAGTGATGACCTGGCCGT-3    . Real-time PCR 
was performed on a Smart Cycler (Cepheid), and the results were analyzed 
by the comparative C  T   method described by the Smart Cycler software. 
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